Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Peringkat dalam Saham #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Harga Saham
$154.04
Kapitalisasi Pasar
$2.21B
Perubahan (1 hari)
-0.19%
Perubahan (1 tahun)
172.88%
Negara
US
Perdagangan Palvella Therapeutics, Inc. (PVLA)

Kategori

Riwayat pemecahan saham untuk Palvella Therapeutics, Inc. (PVLA)
Saham Palvella Therapeutics, Inc. (simbol: PVLA) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 27, 2026.
Satu lembar saham PVLA yang dibeli sebelum Aug 27, 2026 sekarang setara dengan 0 lembar saham PVLA.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH